Extracorporeal shock wave lithotripsy (ESWL) is non-invasive treatment used to break up kidney stones and gallstones using shock wave. Shock wave lithotripsy offers advantages over traditional surgery as it allows treatment of stones without any incision. Growing prevalence of kidney stones globally is driving the demand for ESWL procedures. The global Extracorporeal shock wave lithotripsy Market is estimated to be valued at US$ 443 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The growing prevalence of kidney stones presents a major market opportunity for extracorporeal shock wave lithotripsy providers. According to new studies, around 12% of the global population is likely to develop kidney stones during their lifetime. Risk factors such as poor diet, genetics, and excessive calcium intake have contributed to rising incidence rate globally. ESWL offers minimal invasive treatment options for such a large patient pool suffering from kidney stones. With limited treatment alternatives, demand for ESWL is expected to surge significantly over the forecast period. Manufacturers can capitalize on this opportunity by expanding access to ESWL devices and training medical professionals. Aggressive marketing campaigns to raise awareness regarding ESWL benefits can further aid in tapping into this lucrative growth opportunity.
Porter’s Analysis
Threat of new entrants: The Extracorporeal Shock Wave Lithotripsy market requires high initial investment cost for R&D, manufacturing, and marketing of devices. Stringent regulations also act as a barrier for new companies.
Bargaining power of buyers: Individual buyers have low bargaining power due to specialized nature of devices and dependence of hospitals. However, large hospitals can negotiate on price and demand advanced features.
Bargaining power of suppliers: Few companies manufacture shockwave generators and other key components. This concentrates supplier power. Technology advancements also aid existing suppliers’ dominance.
Threat of new substitutes: Other minimally invasive treatments like ureteroscopy provide substitution threat. However, ESWL is preferred for its non-invasive nature and effectiveness in breaking stones.
Competitive rivalry: Global players compete on technology, product portfolio, price, branding and geographic expansion. Local companies challenge through cost-leadership.
SWOT Analysis
Strength: Non-invasive procedure, high success rates, and portable devices improve accessibility.
Weakness: Require skilled technicians, contraindications in few patients, and chance of stone fragments remaining.
Opportunity: Rising geriatric population and burden of urolithiasis, and growth in medical tourism.
Threats: Reimbursement cuts and increasing adoption of alternatives like ureteroscopy.
Key Takeaways
The Global Extracorporeal Shock Wave Lithotripsy Market Demand is expected to witness high growth supported by rising disease incidence, technological advancements, and increasing medical expenditures.
North America dominates due to large patient pool, favourable reimbursements, and high device adoption. However, Asia Pacific is poised to be the fastest growing region owing to growing healthcare investments, rising medical tourism, and increasing disposable incomes.
Key players operating in the Extracorporeal Shock Wave Lithotripsy market are William Grant & Sons, Pernod Ricard, Diageo Plc, Bacardi Limited, Suntory Holdings, Aceo Ltd., Ben Nevis Distillery, Edrington, Louis Vuitton Moët Hennessy and Gordon & MacPhail. These companies are focused on expanding their product portfolio and global footprint through mergers & acquisitions. Launch of innovative devices integrated with imaging systems and digitized workflows will further aid their market shares.
Get More Insights Here
This report studies the global Extracorporeal Shock-wave Lithotripsy (ESWL) market, analyzes and researches the Extracorporeal Shock-wave Lithotripsy (ESWL) development status and forecast in United States, EU, Japan, China, India and Southeast Asia.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/2085865?utm_source=r0h!tThis report focuses on the top players in global market, like STORZEMDAllengersEdaptmsMTSJena medtechDirex-InitiaMS WestfaliaMedispecSiemensWIKKONSodyDornierRichard WolfHydeHaibinComermy NanyangGemssElmedMarket segment by Regions/Countries, this report covers United StatesEUJapanChinaIndiaSoutheast AsiaBrowse the complete report @ http://orbisresearch.com/reports/index/global-extracorporeal-shock-wave-lithotripsy-eswl-market-size-status-and-forecast-2025?utm_source=r0h!tMarket segment by Type, the product can be split into X-Ray Extracorporeal Shock Wave LithotripsyB-Ultrasound Extracorporeal Shock Wave LithotripsyX-Ray& B-Ultrasound Extracorporeal Shock Wave LithotripsyMarket segment by Application, Extracorporeal Shock-wave Lithotripsy (ESWL) can be split into Kidney StoneBiliary CalculiSalivary StonesPancreatic StonesOthersIf you have any special requirements, please let us know and we will offer you the report as you want.Place a purchase order of this report @ http://orbisresearch.com/contact/purchase/2085865?utm_source=r0h!tAbout Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required market research study for our clients.
